455 related articles for article (PubMed ID: 7678266)
1. Differential antimitogenic effectiveness of atrial natriuretic peptides in primary versus subcultured rat aortic smooth muscle cells: relationship to expression of ANF-C receptors.
Cahill PA; Hassid A
J Cell Physiol; 1993 Jan; 154(1):28-38. PubMed ID: 7678266
[TBL] [Abstract][Full Text] [Related]
2. Clearance receptor-binding atrial natriuretic peptides inhibit mitogenesis and proliferation of rat aortic smooth muscle cells.
Cahill PA; Hassid A
Biochem Biophys Res Commun; 1991 Sep; 179(3):1606-13. PubMed ID: 1656960
[TBL] [Abstract][Full Text] [Related]
3. Atrial and C-type natriuretic peptides amplify growth factor activity in primary aortic smooth muscle cells.
Dhaunsi GS; Hassid A
Cardiovasc Res; 1996 Jan; 31(1):37-47. PubMed ID: 8849587
[TBL] [Abstract][Full Text] [Related]
4. ANF-C-receptor-mediated inhibition of aortic smooth muscle cell proliferation and thymidine kinase activity.
Cahill PA; Hassid A
Am J Physiol; 1994 Jan; 266(1 Pt 2):R194-203. PubMed ID: 8304541
[TBL] [Abstract][Full Text] [Related]
5. L-Citrulline, the by-product of nitric oxide synthesis, decreases vascular smooth muscle cell proliferation.
Ruiz E; Del Rio M; Somoza B; Ganado P; Sanz M; Tejerina T
J Pharmacol Exp Ther; 1999 Jul; 290(1):310-3. PubMed ID: 10381792
[TBL] [Abstract][Full Text] [Related]
6. [Homologous and heterologous regulation of atrial natriuretic factor receptors in smooth muscle cells].
Chabrier PE; Roubert P; Braquet P
Arch Mal Coeur Vaiss; 1989 Jul; 82(7):1249-51. PubMed ID: 2554838
[TBL] [Abstract][Full Text] [Related]
7. Rat renal preglomerular vessels, glomeruli and papillae do not express detectable quantities of B-type natriuretic peptide receptor.
de Leon H; Bonhomme MC; Garcia R
J Hypertens; 1994 May; 12(5):539-48. PubMed ID: 7930554
[TBL] [Abstract][Full Text] [Related]
8. Inhibition by HS-142-1, a novel nonpeptide atrial natriuretic peptide antagonist of microbial origin, of atrial natriuretic peptide-induced relaxation of isolated rabbit aorta through the blockade of guanylyl cyclase-linked receptors.
Imura R; Sano T; Goto J; Yamada K; Matsuda Y
Mol Pharmacol; 1992 Dec; 42(6):982-90. PubMed ID: 1362244
[TBL] [Abstract][Full Text] [Related]
9. Atrial natriuretic factor inhibits mitogen-induced growth in aortic smooth muscle cells.
Baldini PM; De Vito P; Fraziano M; Mattioli P; Luly P; Di Nardo P
J Cell Physiol; 2002 Oct; 193(1):103-9. PubMed ID: 12209885
[TBL] [Abstract][Full Text] [Related]
10. Signaling pathways involved in atrial natriuretic factor and dopamine regulation of renal Na+, K+ -ATPase activity.
Correa AH; Choi MR; Gironacci M; Valera MS; Fernández BE
Regul Pept; 2007 Jan; 138(1):26-31. PubMed ID: 17005263
[TBL] [Abstract][Full Text] [Related]
11. Interactions of atrial natriuretic peptide with A7r5 cells.
Aptel HB; Deacon CF; Henderson IW
Biochem Biophys Res Commun; 1994 Nov; 204(3):1286-91. PubMed ID: 7526862
[TBL] [Abstract][Full Text] [Related]
12. Role of phosphodiesterase 3 in NO/cGMP-mediated antiinflammatory effects in vascular smooth muscle cells.
Aizawa T; Wei H; Miano JM; Abe J; Berk BC; Yan C
Circ Res; 2003 Sep; 93(5):406-13. PubMed ID: 12919948
[TBL] [Abstract][Full Text] [Related]
13. Atrial natriuretic peptide-C receptor-induced attenuation of adenylyl cyclase signaling activates phosphatidylinositol turnover in A10 vascular smooth muscle cells.
Mouawad R; Li Y; Anand-Srivastava MB
Mol Pharmacol; 2004 Apr; 65(4):917-24. PubMed ID: 15044621
[TBL] [Abstract][Full Text] [Related]
14. Atrial natriuretic factor stimulates renal dopamine uptake mediated by natriuretic peptide-type A receptor.
Fernández BE; Correa AH; Choi MR
Regul Pept; 2005 Jan; 124(1-3):137-44. PubMed ID: 15544851
[TBL] [Abstract][Full Text] [Related]
15. Atrial natriuretic factor (ANF) inhibits arginine vasopressin-stimulated Ca2+ fluxes and cell contraction in vascular smooth muscle cells.
Meyer-Lehnert H; Tsai P; Schrier RW
Klin Wochenschr; 1987; 65 Suppl 8():115-21. PubMed ID: 3037182
[TBL] [Abstract][Full Text] [Related]
16. Functional analysis of natriuretic peptide receptors in the bladder of the toad, Bufo marinus.
Meier SK; Donald JA
Gen Comp Endocrinol; 2002 Feb; 125(2):207-17. PubMed ID: 11884066
[TBL] [Abstract][Full Text] [Related]
17. Neuromodulatory effects of atrial natriuretic peptides correlate with an inhibition of adenylate cyclase but not an activation of guanylate cyclase.
Drewett JG; Ziegler RJ; Trachte GJ
J Pharmacol Exp Ther; 1992 Feb; 260(2):689-96. PubMed ID: 1346640
[TBL] [Abstract][Full Text] [Related]
18. Development of natriuretic peptide analogs selective for the atrial natriuretic factor-R1A receptor subtype.
Mimeault M; Fournier A; Féthiere J; De Léan A
Mol Pharmacol; 1993 May; 43(5):775-82. PubMed ID: 8502232
[TBL] [Abstract][Full Text] [Related]
19. Presence and biological activity of C-type natriuretic peptide-dependent guanylate cyclase-coupled receptor in the penile corpus cavernosum.
Kim SZ; Kim SH; Park JK; Koh GY; Cho KW
J Urol; 1998 May; 159(5):1741-6. PubMed ID: 9554404
[TBL] [Abstract][Full Text] [Related]
20. Catalytic activation of guanylate cyclase/atrial natriuretic factor receptor by combined effects of ANF and GTP gamma S in plasma membranes of Leydig tumor cells: involvement of G-proteins.
Khurana ML; Pandey KN
Arch Biochem Biophys; 1995 Jan; 316(1):392-8. PubMed ID: 7840642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
